1.       Abdel-Aziz SM, Rahman MSMA, Shoreit AH, et al. Outcome of infants with hypoxic-ischemic encephalopathy treated by whole body cooling and magnesium sulfate. J Child Sci. 2021; 11: e280–286.

2.       Alsina M, Martin-Ancel A, Alarcon-Allen A, et al. The severity of hypoxic-ischemic encephalopathy correlates with multiple organ dysfunction in the hypothermia era. Pediatr Crit Care Med. 2017; 18: 234–240.

3.       Altit G, Levy PT. Cardiopulmonary Impact of Hypoxic Ischemic Encephalopathy in Newborn Infants. The Emerging Role of Early Hemodynamic Assessment in Determining Adverse Neurological Outcomes. Am J Respir Crit Care Med. 2019; 200(10): 1206-1207.

4.       Azzopardi D, Chew AT, Deierl A, et al. Prospective qualification of early cerebral biomarkers in a randomised trial of treatment with xenon combined with moderate hypothermia after birth asphyxia. EBioMedicine. 2019; 47: 484–491.

5.       Bano S, Chaudhary V, Garga UC. Neonatal hypoxic-ischemic encephalopathy: a radiological review. J Pediatr Neurosci. 2017; 12:1–6.

6.       Chalak L. New Horizons in Mild Hypoxic-ischemic Encephalopathy: A Standardized Algorithm to Move past Conundrum of Care. Clin Perinatol. 2022; 49(1): 279-294.

7.       Chen Y, Zhang J. How Energy Supports Our Brain to Yield Consciousness: Insights From Neuroimaging Based on the Neuroenergetics Hypothesis. Frontiers in Systems Neuroscience. 2021; 15: 2021.

8.       Cohen SS, Sprecher AJ, Acharya KK. Hypoxic-ischemic encephalopathy. Nelson Textbook of Pediatrics. 22nd ed: Elsevier; 2024: 1062-1068.

9.       Committee on Fetus and Newborn; Papile LA, Baley JE, Benitz W,et al. Hypothermia and neonatal encephalopathy. Pediatrics. 2014; 133(6): 1146-1150.

10.   Cornet M, Kuzniewicz M, Scheffler A, et al. Perinatal Hypoxic-Ischemic Encephalopathy: Incidence Over Time Within a Modern US Birth Cohort. Pediatric Neurology. 2023; 149: 145-150.

11.   El-Dib M, Abdelgadir D, Ahmad KA, et al. Benefits and risks of therapeutic hypothermia for hypoxic-ischemic encephalopathy in late preterm infants. Pediatr Res. 2025 Sep 18. doi: 10.1038/s41390-025-04428-9. Epub ahead of print. PMID: 40968225.

12.   Goel M, Dwivedi R, Gohiya P, et al. Nucleated red blood cell in cord blood as a marker of perinatal asphyxia. Journal of Clinical Neonatology. 2013; 2(4): 179.

13.   Groenendaal F. Hypoxic-ischemic encephalopathy. In Martin R, Fanaroff A, Walsh M, editors, Fanaroff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 11th ed. Elsevier; 2019: 904-926.

14.   Hillman TC, Jacobson B, Piaggio Hurtado De Medoza K, et al. Inflammation mediated brain damage and cytokine expression in a maternally derived murine model for preterm hypoxic-ischemic encephalopathy. Front. Syst. Biol. 2025; 5: 1517712.

15.   Jerez-Calero A, Salvatierra-Cuenca MT, Benitez-Feliponi Á, et al. Hypothermia plus melatonin in asphyctic newborns: A Randomized-Controlled Pilot Study. Pediatr Crit Care Med. 2020; 21: 647–655.

16.   Katar S, Devecioğlu C, Sucaklı İ, ve ark. Hipoksik iskemik ensefalopatili 80 Term yenidoğan hastanın değerlendirilmesi. Dicle Tıp Dergisi. 2007; 34(1): 38-41.

17.   Kukka AJ, Waheddoost S, Brown N, et al. Incidence and outcomes of intrapartum-related neonatal encephalopathy in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Glob Health. 2022;7(12):e010294.

18.   Lee AC, Kozuki N, Blencowe H, et al. Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res. 2013; 74(S1): 50-72.

19.   Mashat S, Bitar L, Mir IN, et al. Placental inflammatory response and association with the severity of neonatal hypoxic ischemic encephalopathy. Early Hum Dev. 2025; 201: 106179.

20.   Modisett AK, Patel RM, Jernigan SM, et al. Patterns of acute kidney and hepatic injury and association with adverse outcomes in infants undergoing therapeutic hypothermia for hypoxic ischemic encephalopathy. J Perinatol. 2022; 42(10): 1361-1367.

21.   Murray DM, Boylan GB, Ryan CA, et al. Early EEG findings in hypoxic-ischemic encephalopathy predict outcomes at 2 years. Pediatrics. 2009; 124(3): e459-467.

22.   Nadeem M, Murray DM, Boylan GB, et al. Early blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy. BMC Pediatr. 2011; 11: 10.

23.   O'Dea M, Sweetman D, Bonifacio SL, et al. Management of Multi Organ Dysfunction in Neonatal Encephalopathy. Front. Pediatr. 2020; 8: 239.

24.   Palmer C, Towfighi J, Roberts RL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr. Res. 1993; 33: 405–411.

25.   Pang R, Han HJ, Meehan C, et al. Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia. Ann Clin Transl Neurol, 2022; 9: 795-809.

26.   Ranjan AK, Gulati A. Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy. J Clin Med. 2023; 12(20): 6653.

27.   Ravichandran L, Allen VM, Allen AC, et al. Incidence, intrapartum risk factors, and prognosis of neonatal hypoxic-ischemic encephalopathy among infants born at 35 weeks gestation or more. J Obstet Gynaecol Can. 2020; 42(12): 1489–1497.

28.   Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. a clinical and electroencephalographic study. Arch Neurol. 1976; 33: 696–705.

29.   Satar M, Narlı N, Kırımi E, ve ark. Hipoksik iskemik ensefalopatili 205 olgunun değerlendirilmesi. T Klin Pediatri. 2001; 10(1): 36-41.

30.   Serrenho I, Rosado M, Dinis A, et al. Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies. Int J Mol Sci. 2021; 22(6): 3142.

31.   Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353: 1574–1584.

32.   Shankaran S, McDonald SA, Laptook AR, et al. Neonatal magnetic resonance imaging pattern of brain injury as a biomarker of childhood outcomes following a trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2015; 167: 987.

33.   Spies EE, Lababidi SL, McBride MC. Early hyperglycemia is associated with poor gross motor outcome in asphyxiated term newborns. Pediatr Neurol. 2014; 50: 586–590.

34.   Thompson CM, Puterman AS, Linley LL, et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997; 86: 757-761.

35.   Türk Neonatoloji Derneği Hipoksik İskemik Ensefalopati Çalışma Grubu. Türkiye’de yenidoğan yoğun bakım ünitelerinde izlenen hipoksik iskemik ensefalopatili olgular, risk faktörleri, insidans ve kısa dönem prognozları. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008; 51(3): 123-129.

36.   Victor S, Rahim A, Rocha-Ferreira, et al. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr. 2022; 181: 875-887.

37.   Volpe JJ. Hypoxic-ischemic injury in the term infant: pathophysiology. In: Volpe's Neurology of the Newborn, 7th ed. Elsevier; 2018: 500-509.

38.   Wu L, Chang E, Zhao H, et al. Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview. Cell Death Discov. 2024; 10(1): 277.

39.   Wu YW, Comstock BA, Gonzalez FF, et al. HEAL Consortium. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. N Engl J Med. 2022; 387: 148-159.